Moreover, it has been documented that the cisplatin influx promoted by the organic cation transport 1 (OCT1) in esophageal squamous cell carcinoma shows a significant positive correlation between a low expression of OCT1 and a reduced sensitivity to cisplatin, along with a poor prognosis [24]. The gene discussed is SLC22A1; the disease is esophageal squamous cell carcinoma.